dizziness tirzepatide Is a Side Effect of Mounjaro? Understanding the Implications and Management Strategies – PlexusDx Zepbound Dizziness and Other Side

There is limited clinical data specifically on microdosing protocols

Tirzepatide is a GLP-1/GIP receptor agonist licensed by MHRA for type 2 diabetes and weight management in adults with obesity or overweight with comorbidities

The company was cleared to manufacture and market a once-weekly injectable treatment for adults whose type 2 diabetes is not adequately controlled

Medication choice should be individualized, not trend-driven. Up next in this series: Are weight loss medications safe long term and what we actually know from the data

Mounjaro (active ingredient: tirzepatide) subcutaneous injection Initial FDA Approval: 2022 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting

Stress lingers